Search results

• 2012

  First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

  Lee, S. M., Khan, I., Upadhyay, S., Lewanski, C., Falk, S., Skailes, G., Marshall, E., Woll, P. J., Hatton, M., Lal, R., Jones, R., Toy, E., Chao, D., Middleton, G., Bulley, S., Ngai, Y., Rudd, R., Hackshaw, A. & Boshoff, C., Nov 2012, In: The Lancet Oncology. 13, 11, p. 1161-1170 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Chemotherapy 100%
  160 Citations (Scopus)